Failure of low doses of /sup 131/I to ablate residual thyroid tissue following surgery for thyroid cancer
Conference
·
· Radiology; (United States)
OSTI ID:6687669
Thirteen patients received an initial dose of 25-29.9 mCi (925-1106 MBq) of /sup 131/I following partial thyroidectomy for papillary, follicular, or mixed carcinoma. Administration of thyroxine (T/sub 4/) or triiodothyronine (T/sub 3/) was stopped 3-12 weeks and 1-6 weeks, respectively, before therapy or imaging. Patients remained on normal diets and did not receive thyroid stimulating hormone (TSH) or diuretics. Follow-up 3 months to 2 years after therapy demonstrated that ablation of thyroid bed activity was successful in only one patient, who still had metastases. This suggests that administration of 25-29.9 mCi of /sup 131/I following surgery is unreliable for ablation of residual thyroid bed activity.
- Research Organization:
- Veterans Administration Medical Center, Denver, CO
- OSTI ID:
- 6687669
- Conference Information:
- Journal Name: Radiology; (United States) Journal Volume: 137:3
- Country of Publication:
- United States
- Language:
- English
Similar Records
Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma
Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma
Serial TSH determination after T/sub 3/ withdrawal or thyroidectomy in the therapy of thyroid carcinoma. [I-131]
Journal Article
·
Tue Mar 31 23:00:00 EST 1981
· Clin. Nucl. Med.; (United States)
·
OSTI ID:5503856
Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma
Journal Article
·
Tue Mar 31 23:00:00 EST 1981
· Clin. Nucl. Med.; (United States)
·
OSTI ID:5794828
Serial TSH determination after T/sub 3/ withdrawal or thyroidectomy in the therapy of thyroid carcinoma. [I-131]
Journal Article
·
Sat Sep 01 00:00:00 EDT 1979
· J. Nucl. Med.; (United States)
·
OSTI ID:5825357
Related Subjects
550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
551001 -- Physiological Systems-- Tracer Techniques
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
AMINO ACIDS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
CARBOXYLIC ACIDS
CARCINOMAS
DAYS LIVING RADIOISOTOPES
DIET
DISEASES
DOSES
ENDOCRINE GLANDS
EVALUATION
GLANDS
HORMONES
INTERMEDIATE MASS NUCLEI
INTERNAL IRRADIATION
IODINE 131
IODINE ISOTOPES
IRRADIATION
ISOTOPES
MEDICAL SURVEILLANCE
MEDICINE
METASTASES
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANIC ACIDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC IODINE COMPOUNDS
ORGANS
PATIENTS
PEPTIDE HORMONES
PITUITARY HORMONES
RADIATION DOSES
RADIATION EFFECTS
RADIOISOTOPES
RADIOLOGY
RADIONUCLIDE KINETICS
RADIOTHERAPY
SURGERY
SURVEILLANCE
THERAPY
THYROID
THYROID HORMONES
THYROIDECTOMY
THYROXINE
TRIIODOTHYRONINE
TSH
551001 -- Physiological Systems-- Tracer Techniques
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
AMINO ACIDS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
CARBOXYLIC ACIDS
CARCINOMAS
DAYS LIVING RADIOISOTOPES
DIET
DISEASES
DOSES
ENDOCRINE GLANDS
EVALUATION
GLANDS
HORMONES
INTERMEDIATE MASS NUCLEI
INTERNAL IRRADIATION
IODINE 131
IODINE ISOTOPES
IRRADIATION
ISOTOPES
MEDICAL SURVEILLANCE
MEDICINE
METASTASES
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANIC ACIDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC IODINE COMPOUNDS
ORGANS
PATIENTS
PEPTIDE HORMONES
PITUITARY HORMONES
RADIATION DOSES
RADIATION EFFECTS
RADIOISOTOPES
RADIOLOGY
RADIONUCLIDE KINETICS
RADIOTHERAPY
SURGERY
SURVEILLANCE
THERAPY
THYROID
THYROID HORMONES
THYROIDECTOMY
THYROXINE
TRIIODOTHYRONINE
TSH